BMB Reports Papers in Press available online.

Search Papers In Press
This galley proof is being listed electronically before publishing the final manuscript (It's not final version).

Neoagarohexaose activates dendritic cells via Toll-like receptor 4, leading to stimulation of natural killer cells and enhancement of antitumor immunity
Moon Hee Lee1, Jong-Hwa Jang2, Gun Young Yun1, Min-Goo Lee3, Tae Heung Kang1, Hee Dong Han1, Seung Jun Lee1, Hyuk Soon Kim1, Wahn Soo Choi1, Yeong-Min Park1,*, Won Sun Park4, In Duk Jung1
1Department of Immunology, Konkuk University,
2Department of Dental Hygiene, Hanseo University,
3Department of Physiology, Korea University,
4Department of Physiology, Kangwon National University
b-agarase cleaves b-1,4 linkages of agar to produce neoagarooligosaccharides (NAO), which are associated with various physiological functions. However, the immunological functions of NAO are still unclear. In this study, we demonstrated that b-agarase DagA-produced neoagarohexaose (DP6), one among the many NAO products, promotes the maturation of dendritic cells (DCs) by Toll-like receptor 4 (TLR4). DP6 directly and indirectly enhanced the activation of natural killer (NK) cells in a TLR4-dependent manner in vitro and in vivo. Finally, the antitumor activity of DP6 against B16F1 melanoma cells was inhibited in NK cell-depletion systems by using NK-cell depleting antibodies in vivo. Taken together, the results indicate that DP6 augments antitumor immunity against B16F1 melanoma cells via the activation of DC-mediated NK cell activity in a TLR4-dependent manner. These results suggest that DP6 might be a promising candidate adjuvant that acts as an immune cell modulator for the treatment of melanoma.
Abstract, Accepted Manuscript(in press) [Submitted on February 8, 2017, Accepted on March 9, 2017]
  Copyright © KSBMB. All rights reserved. / Powered by, Ltd